Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies-Reference-Cited by-同舟云学术

Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies

Published:2002-11 Issue:8 Volume:12 Page:605-611
ISSN:0960-314X
Container-title:Pharmacogenetics
language:en
Short-container-title:Pharmacogenetics

Author:

Blanco Javier G,Edick Mathew J,Hancock Michael L,Winick Naomi J,Dervieux Thierry,Amylon Michael D,Bash Robert O,Behm Frederick G,Camitta Bruce M,Pui Ching-Hon,Raimondi Susana C,Relling Mary V

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Pharmacology, Toxicology and Pharmaceutics,Genetics

Reference36 articles.

1. Acute Lymphoblastic Leukemia

2. Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia

3. Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study.

4. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia

5. TOPOISOMERASE II INHIBITOR-RELATED ACUTE MYELOID LEUKAEMIA

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review;Cancer Epidemiology, Biomarkers & Prevention;2024-05-27

2. Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy in Children with Cancer: A Systematic Review and Meta-Analysis;Cancers;2022-01-26

3. Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes;Cancer Chemotherapy and Pharmacology;2019-07-15

4. Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection;European Journal of Clinical Pharmacology;2019-03-12

5. Germline polymorphisms and the risk of therapy-related myeloid neoplasms;Best Practice & Research Clinical Haematology;2019-03